Physician profile
Jon P Walker
NPI 1588716237
$1,356.20
in general payments reported to CMS, 2019-2025
12 companies · $59.73 in 2025
The $59.73 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2022: $256 · 2023: $372 · 2024: $346 · 2025: $59.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762 · Education: $15.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.09 |
| Education | $15.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $331.26 | 2022-2023 | Axios |
| Fujifilm Healthcare Americas Corporation | $193.38 | 2024 | Fujifilm |
| Pfizer INC. | $145.00 | 2019 | |
| Medtronic, INC. | $144.11 | 2022 | |
| Qol Medical, LLC | $135.45 | 2023 | Sucraid |
| Phathom Pharmaceuticals, INC. | $125.86 | 2024 | Voquezna |
| Gilead Sciences, INC. | $103.95 | 2019 | |
| Intercept Pharmaceuticals, INC. | $73.39 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.89 | 2025 | Entyvio |
| Genzyme Corporation | $26.58 | 2024 | |
| Abbvie INC. | $18.84 | 2025 | |
| Ferring Pharmaceuticals INC. | $17.49 | 2023 | Rebyota |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.